NYSE American - Delayed Quote USD

Cryo-Cell International, Inc. (CCEL)

5.09

+0.22

+(4.53%)

At close: May 8 at 3:44:30 PM EDT

5.09

0.00

(0.00%)

After hours: May 8 at 4:05:12 PM EDT

Key Events

Advanced Chart

Loading Chart for CCEL

Previous Close 4.87
Open 5.03
Bid 4.85 x 1400
Ask 5.50 x 900
Day's Range 4.94 - 5.09
52 Week Range 4.75 - 9.50
Volume 3,553
Avg. Volume 14,400
Market Cap (intraday) 41.179M
Beta (5Y Monthly) 0.81
PE Ratio (TTM) 509.50
EPS (TTM) 0.01
Earnings Date Jul 14, 2025 - Jul 18, 2025
Forward Dividend & Yield 1.00 (20.52%)
Ex-Dividend Date Feb 14, 2025
1y Target Est 8.50

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

www.cryo-cell.com

Full Time Employees

November 30

Fiscal Year Ends

Healthcare

Sector

Medical Care Facilities

Industry

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

YTD Return

CCEL

28.99%

S&P 500 (^GSPC)

3.70%

1-Year Return

CCEL

38.02%

S&P 500 (^GSPC)

9.18%

3-Year Return

CCEL

4.78%

S&P 500 (^GSPC)

37.36%

5-Year Return

CCEL

10.57%

S&P 500 (^GSPC)

93.32%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

CCEL

Cryo-Cell International, Inc.

5.10

+4.53%

Mkt Cap 41.179M